Avid Bioservices CDMO reported its Q2 earnings results on Tuesday, December 7, 2021 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Avid Bioservices beat estimated earnings by 200%, reporting an EPS of $0.06 versus an estimate of $0.02, which surprised analysts.
Revenue was up $5,045,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.06, which was followed by a 12.05% drop in the share price the next day.
Here's a look at Avid Bioservices's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.04 | -0.03 | -0.06 | |
| EPS Actual | 0.10 | -0.04 | 0.01 | 0.01 |
| Revenue Estimate | 27.81M | 21.60M | 19.07M | 15.49M |
| Revenue Actual | 30.75M | 27.61M | 21.81M | 21.06M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.